Intellipharmaceutics International Inc. (IPCI)

[grill4thrills]

I wouldn’t be too sure that this is 100% negative. Perhaps it even allows IPCI to gain revenue as they may be able to manufacture themselves on a cost plus basis like their deal with Mallinckrodt. Or maybe IPCI’s approval on other strengths is on the heels of this one as Par likely had to jump through similar hoops for their ANDA requirements as IPCI’s version. Of course, it may hurt changing their sales face from Par to whomever if that be the case down the road. There is just nothing known at this point, so wait and see.